Ken Nakagawa - Publications, H-index & Citations

Ken Nakagawa

Keio University

49H指数

555论文数

1.2W被引数

收录论文 138

发表时间

Dual single-nucleotide polymorphism biomarker combination to select opioid for cancer pain management 双重单核苷酸多态性生物标志物组合用于选择阿片类药物进行癌痛管理

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Fujita, Y.; Matsuoka, H.; Tsurutani, J.; Yoshida, T.; Koyama, A.; Nishio, K.; Nakagawa, K.

Increased serum creatinine associated with testicular microlithiasis in adult Japanese men: A retrospective cohort study

ANDROLOGY

IF3.4

2023-11-27

PREAI

Hagiuda, Jun; Takamatsu, Kiyoshi; Nakagawa, Ken

The efficacy of rituximab treatment for antibody-mediated rejection in liver transplantation: A retrospective Japanese nationwide study 利妥昔单抗治疗肝移植中抗体介导的排斥反应的疗效: 一项回顾性日本全国性研究

HEPATOLOGY RESEARCH

IF3.4

2021-04-20

PREAI

Sakamoto, Seisuke; Akamatsu, Nobuhisa; Hasegawa, Kiyoshi; Ohdan, Hideki; Nakagawa, Ken; Egawa, Hiroto

Efficacy of a hydrogel spacer in 3D-CRT for prostate cancer

RADIOTHERAPY AND ONCOLOGY

IF5.3

2019-04-01

OAAI

Ogita, M.; Yamashita, H.; Sawayanagi, S.; Takahashi, W.; Nakagawa, K.

Adjuvant radiotherapy for primary squamous cell carcinoma of the breast

RADIOTHERAPY AND ONCOLOGY

IF5.3

2019-04-01

OAAI

Ogita, M.; Shiraishi, K.; Chang, T.; Kawamori, J.; Takahashi, W.; Kiritoshi, T.; Yamashita, H.; Nakagawa, K.

Salvage SBRT for postoperative recurrence of NSCLC

RADIOTHERAPY AND ONCOLOGY

IF5.3

2019-04-01

OAAI

Aoki, S.; Yamashita, H.; Takahashi, W.; Nawa, K.; Ota, T.; Nozawa, Y.; Ozaki, S.; Nakamoto, T.; Nakagawa, K.

Considering adequate amount of palbociclib due to neutropenia in 28 Japanese patients with advanced breast cancer - real world data of single institution

BREAST

IF7.9

2019-03-01

PREAI

Hirokawa, E.; Iwasa, T.; Sakai, H.; Watanabe, S.; Yonesaka, K.; Komoike, Y.; Nakagawa, K.

ADRB2 gene polymorphism and emphysema heterogeneity can modulate bronchodilator response in patients with emphysema

PULMONARY PHARMACOLOGY & THERAPEUTICS

IF2.8

2018-02-01

PREAI

Nojiri, Masafumi; Mizuno, Shiro; Nishiki, Kazuaki; Kato, Ryo; Nakagawa, Ken; Oikawa, Taku; Iguchi, Masaharu; Osanai, Kazuhiro; Ishizaki, Takeshi; Toga, Hirohisa

Prognostic Effect of Lymphovascular Invasion on TNM Staging in Stage I Non-Small-cell Lung Cancer 淋巴血管侵犯对I期非小细胞肺癌TNM分期的预后影响

CLINICAL LUNG CANCER

IF3.3

2018-01-01

PREAI

Noma, Daisuke; Inamura, Kentaro; Matsuura, Yosuke; Hirata, Yoshifumi; Nakajima, Takuya; Yamazaki, Hirotsugu; Hirai, Yoshimitsu; Ichinose, Junji; Nakao, Masayuki; Ninomiya, Hironori; Mun, Mingyon; Nakagawa, Ken; Masuda, Munetaka; Ishikawa, Yuichi; Okumura, Sakae

The Conditional Survival with Time of Intravesical Recurrence of Upper Tract Urothelial Carcinoma

JOURNAL OF UROLOGY

IF6.8

2017-12-01

PREAI

Shigeta, Keisuke; Kikuchi, Eiji; Hagiwara, Masayuki; Ando, Toshiyuki; Mizuno, Ryuichi; Abe, Takayuki; Mikami, Shuji; Miyajima, Akira; Nakagawa, Ken; Oya, Mototsugu

CT-Based Radiomics Histology Analysis of Stereotactic Ablative Radiation Therapy Patients with Early-Stage Non-small Cell Lung Cancer

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2017-10-01

OAAI

Takahashi, W.; Aoki, S.; Yamashita, H.; Ogita, M.; Nakagawa, K.; Haga, A.

p53 Signaling Pathway Polymorphisms Associated With Emphysematous Changes in Patients With COPD

CHEST

IF8.6

2017-07-01

PREAI

Mizuno, Shiro; Ishizaki, Takeshi; Kadowaki, Maiko; Akai, Masaya; Shiozaki, Kohei; Iguchi, Masaharu; Oikawa, Taku; Nakagawa, Ken; Osanai, Kazuhiro; Toga, Hirohisa; Gomez-Arroyo, Jose; Kraskauskas, Donatas; Cool, Carlyne D.; Bogaard, Herman J.; Voelkel, Norbert F.

USEFULNESS OF INFLAMMATORY MARKER DYNAMICS ONE MONTH AFTER THE FIRST-LINE TARGETED THERAPY INITIATION FOR PFS PREDICTION IN PATIENTS WITH METASTATIC CLEAR CELL RENAL CELL CARCINOMA

JOURNAL OF UROLOGY

IF6.8

2017-04-01

OAAI

Ito, Keiichi; Masunaga, Ayako; Tanaka, Nobuyuki; Mizuno, Ryuichi; Shirotake, Suguru; Yasumizu, Yota; Ito, Yujiro; Miyazaki, Yasumasa; Hagiwara, Masayuki; Kanao, Kent; Mikami, Shuji; Monma, Tetsuo; Nakagawa, Ken; Masuda, Tsuyoshi; Oyama, Masafumi; Asano, Tomohiko; Oya, Mototsugu

Successful low-dose leflunomide treatment for ganciclovir-resistant cytomegalovirus infection with high-level antigenemia in a kidney transplant: A case report and literature review

JOURNAL OF CLINICAL VIROLOGY

IF3.4

2016-09-01

PREAI

Morita, Shinya; Shinoda, Kazunobu; Tamaki, Satoshi; Kono, Hidaka; Asanuma, Hiroshi; Nakagawa, Ken; Oya, Mototsugu

External Validation of the MSKCC and IMDC Risk Models in Patients Treated with Targeted Therapy as a First-line and Subsequent Second-line Treatment: A Japanese Multi-institutional Study

EUROPEAN UROLOGY FOCUS

IF5.6

2016-08-01

PREAI

Tanaka, Nobuyuki; Mizuno, Ryuichi; Ito, Keiichi; Shirotake, Suguru; Yasumizu, Yota; Masunaga, Ayako; Ito, Yujiro; Miyazaki, Yasumasa; Hagiwara, Masayuki; Kanao, Kent; Mikami, Shuji; Nakagawa, Ken; Mommai, Tetsuo; Masuda, Takeshi; Asano, Tomohiko; Oyama, Masafumi; Oya, Mototsugu

Changes in pulmonary function after single-fraction carbon-ion radiotherapy for stage I NSCLC

RADIOTHERAPY AND ONCOLOGY

IF5.3

2016-04-01

OAAI

Takahashi, W.; Yamamoto, N.; Nakajima, M.; Karube, M.; Yamashita, H.; Nakagawa, K.; Tsuji, H.; Kamada, T.

CD44V8-10 INVOLVES ACQUISITION OF CISPLATIN-RESISTANCE IN UROTHELIAL CANCER

JOURNAL OF UROLOGY

IF6.8

2016-04-01

OAAI

Hagiwara, Masayuki; Kikuchi, Eiji; Kosaka, Takeo; Mikami, Shuji; Saya, Hideyuki; Nakagawa, Ken; Oya, Mototsugu

EXTERNAL VALIDATION OF PROGNOSTIC IMPACT OF PATIENT AGE AND GENDER IN PATIENTS TREATED WITH RADICAL NEPHROURETERECTOMY: PROPOSED NEW PERSPECTIVE OF GENDER-ADJUSTED AGE IN UPPER TRACT UROTHELIAL CARCINOMA

JOURNAL OF UROLOGY

IF6.8

2016-04-01

OAAI

Kobayashi, Hiroaki; Kikuchi, Eiji; Tanaka, Nobuyuki; Shirotake, Suguru; Miyazaki, Yasumasa; Ide, Hiroki; Obata, Jun; Hoshino, Katsura; Matsumoto, Kazuhiro; Kaneko, Gou; Hagiwara, Masayuki; Kosaka, Takeo; Hara, Satoshi; Miyajima, Akira; Momma, Tetsuo; Nakagawa, Ken; Oya, Mototsugu

A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients (≥75-years-old) with advanced non-squamous, non-small cell lung cancer

EUROPEAN JOURNAL OF CANCER

IF7.1

2015-09-01

PREAI

Tamiya, M.; Tamiya, A.; Kaneda, H.; Nakagawa, K.; Goto, K.; Yoh, K.; Okamoto, H.; Shimokawa, T.; Abe, T.; Tanaka, H.; Daga, H.; Takeda, K.; Atagi, S.; Hirashima, T.

Phase 2: Docetaxel with or without ramucirumab as therapy for non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating mutations after prior EGFR tyrosine kinase inhibitor (TKI) and platinum-based chemotherapy

EUROPEAN JOURNAL OF CANCER

IF7.1

2015-09-01

PREAI

Kasahara, K.; Kiura, K.; Nogami, N.; Takayama, K.; Takiguchi, Y.; Hirashima, T.; Aoe, K.; Hayashi, H.; Saka, H.; Takahashi, K.; Imamura, F.; Oizumi, S.; Inoue, A.; Satouchi, M.; Tatsumi, M.; Nakamura, T.; Enatsu, S.; Tamura, T.; Nakagawa, K.

研究方向